Status:
COMPLETED
Three Dimensional Versus Two Dimensional Laparoscopic Salpingectomy in Patients With Hydrosalpinx Undergoing IVF-ET
Lead Sponsor:
Cairo University
Conditions:
Hydrosalpinx
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
A three-dimensional laparoscopic vision system (3-D LVS) has gained acceptance and is being utilized in daily practice despite debates about its success.
Detailed Description
A three-dimensional laparoscopic vision system (3-D LVS) has gained acceptance and is being utilized in daily practice despite debates about its success. in our study we will compare operative data an...
Eligibility Criteria
Inclusion
- Patients with unilateral hydrosalpinx diagnosed with hysterosalpingography or laparoscopy
Exclusion
- Bilateral hydrosalpinx,
- co-existent adnexal pathology,
- body mass index (BMI) more than 40,
- extensive pelvic adhesions,
- coagulation defects or concurrent anticoagulant therapy,
- compromised cardiopulmonary status,
- and contraindications for general anesthesia.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05195073
Start Date
April 1 2022
End Date
December 30 2022
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12613